Whole-exome sequencing in familial atrial fibrillation

European Heart Journal

Volumn 35, Issue 36, 2014, Pages 2477-2483

  Weeke, Peter ^a,b   Muhammad, Raafia ^a   Delaney, Jessica T ^a   Shaffer, Christian ^a   Mosley, Jonathan D ^a   Blair, Marcia ^a   Short, Laura ^a   Stubblefield, Tanya ^a   Roden, Dan M ^a,c   Darbar, Dawood ^a,c  

^a VANDERBILT UNIVERSITY   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Calcium signalling; Exome; Family study; Genetics

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL CACNA2D4; CALCIUM CHANNEL CACNB2; UNCLASSIFIED DRUG; RNA SPLICING; STOP CODON;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CLINICAL ARTICLE; EXOME; FAMILIAL DISEASE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; ADOLESCENT; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MISSENSE MUTATION; PEDIGREE; REGISTER; RNA SPLICING; STOP CODON; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ATRIAL FIBRILLATION; CODON, NONSENSE; EXOME; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PEDIGREE; REGISTRIES; RNA SPLICE SITES; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84924528473     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu156     Document Type: Article

References (29)

1. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001;37:371-378.
2. Arnar DO, Thorvaldsson S, Manolio TA, Thorgeirsson G, Kristjansson K, Hakonarson H, Stefansson K. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 2006;27:708-712.
3. Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, Arking DE, Muller-Nurasyid M, Krijthe BP, Lubitz SA, Bis JC, Chung MK, Dorr M, Ozaki K, Roberts JD, Smith JG, Pfeufer A, Sinner MF, Lohman K, Ding J, Smith NL, Smith JD, Rienstra M, Rice KM, VanWagoner DR, Magnani JW,Wakili R, Clauss S, Rotter JI, Steinbeck G, Launer LJ, Davies RW, Borkovich M, Harris TB, Lin H, Volker U, Volzke H, Milan DJ, Hofman A, Boerwinkle E, Chen LY, Soliman EZ, Voight BF, Li G, Chakravarti A, Kubo M, Tedrow UB, Rose LM, Ridker PM, Conen D, Tsunoda T, Furukawa T, Sotoodehnia N, Xu S, Kamatani N, Levy D, Nakamura Y, Parvez B, Mahida S, Furie KL, Rosand J, Muhammad R, Psaty BM, Meitinger TPerz S,Wichmann HE,Witteman JC, KaoWH, Kathiresan S, Roden DM, Uitterlinden AG, Rivadeneira F, McKnight B, Sjogren M, Newman AB, Liu Y, Gollob MH, Melander O, Tanaka T, Stricker BH, Felix SB, Alonso A, Darbar D, Barnard J, Chasman DI, Heckbert SR, Benjamin EJ, Gudnason V, Kaab S. Meta-Analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012;44:670-675.
4. Hodgson-Zingman DM, Karst ML, Zingman LV, Heublein DM, Darbar D, Herron KJ, Ballew JD, de Andrade M, Burnett JC Jr., Olson TM. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. New Engl J Med 2008;359:158-165.
5. Weeke P, Parvez B, Blair M, Short L, Ingram C, Kucera G, Stubblefield T, Roden DM, Darbar D. Candidate gene approach to identifying rare genetic variants associated with lone atrial fibrillation. Heart Rhythm 2014;11:46-52.
6. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM. Finding the missing heritability of complex diseases. Nature 2009; 461:747-753.
7. Wells QS, Becker JR, Su YR, Mosley JD, Weeke P, D'Aoust L, Ausborn NL, Ramirez AH, Pfotenhauer JP, Naftilan AJ, Markham L, Exil V, Roden DM, Hong CC. Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy. Circ. Cardiovasc. Genet. 2013;6:317-326.
8. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, Shaffer T, Wong M, Bhattacharjee A, Eichler EE, Bamshad M, Nickerson DA, Shendure J. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009; 461:272-276.
9. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA, Shendure J, Bamshad MJ. Exome sequencing identifies the cause of a Mendelian disorder. Nat. Genet. 2010;42:30-35.
10. Darbar D, Motsinger AA, Ritchie MD, Gainer JV, Roden DM. Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. Heart Rhythm 2007;4:743-749.
11. Norton N, Robertson PD, Rieder MJ, Zuchner S, Rampersaud E, Martin E, Li D, Nickerson DA, Hershberger RE. Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era. Circ. Cardiovasc. Genet. 2012;5:167-174.
12. Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev. Genet. 2011;12:745-755.
13. Cooper GM, Shendure J. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nature reviews. Genetics 2011;12:628-640.
14. Mathieson I, McVean G. Differential confounding of rare and common variants in spatially structured populations. Nat. Genet. 2012;44:243-246.
15. Darbar D, Roden DM. Genetic mechanisms of atrial fibrillation: impact on response to treatment. Nature reviews. Cardiology 2013;00:00-00.
16. Ritchie MD, Rowan S, Kucera G, Stubblefield T, Blair M, Carter S, Roden DM, Darbar D. Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. J. Am. Coll. Cardiol. 2012;60: 1173-1181.
17. Berger SI, Ma'ayan A, Iyengar R. Systems pharmacology of arrhythmias. Science Signaling 2010;3:ra30.
18. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, Guerchicoff A, Pfeiffer R, Oliva A, Wollnik B, Gelber P, Bonaros EP Jr., Burashnikov E, Wu Y, Sargent JD, Schickel S, Oberheiden R, Bhatia A, Hsu LF, Haissaguerre M, Schimpf R, Borggrefe M, Wolpert C. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007;115:442-449.
19. Boczek NJ, Best JM, Tester DJ, Giudicessi JR, Middha S, Evans JM, Kamp TJ, Ackerman MJ. Exome Sequencing and Systems Biology Converge to Identify Novel Mutations in the L-Type Calcium Channel, CACNA1C, Linked to Autosomal Dominant Long QT Syndrome. Circulation. Cardiovascular Genetics 2013;6:279-289.
20. Beetz N, Hein L, Meszaros J, Gilsbach R, Barreto F, Meissner M, Hoppe UC, Schwartz A, Herzig S, Matthes J. Transgenic simulation of human heart failure-like L-type Ca2+-channels: implications for fibrosis and heart rate in mice. Cardiovascular Research 2009;84:396-406.
21. Cordeiro JM, Marieb M, Pfeiffer R, Calloe K, Burashnikov E, Antzelevitch C. Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome. J. Mol. Cell. Cardiol. 2009;46:695-703.
22. Splawski I, TimothyKW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl. Acad. Sci. USA 2005;102:8089-8096; discussion 8086-8.
23. Qin N, Yagel S,MomplaisirML, Codd EE, D'Andrea MR. Molecular cloning and characterization of the human voltage-gated calcium channel alpha(2)delta-4 subunit. Mol. Pharmacol. 2002;62:485-496.
24. Vest JA, Wehrens XH, Reiken SR, Lehnart SE, Dobrev D, Chandra P, Danilo P, Ravens U, Rosen MR, Marks AR. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005;111:2025-2032.
25. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-226.
26. El-Armouche A, Boknik P, Eschenhagen T, Carrier L, Knaut M, Ravens U, Dobrev D. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation 2006;114:670-680.
27. Hove-Madsen L, Llach A, Bayes-Genis A, Roura S, Rodriguez Font E, Aris A, Cinca J. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 2004;110: 1358-1363.
28. Darbar D, Hardy A, Haines JL, Roden DM. Prolonged signal-Averaged P-wave duration as an intermediate phenotype for familial atrial fibrillation. J. Am. Coll. Cardiol. 2008;51:1083-1089.
29. Ellinor PT, LowA, Patton KK, Shea MA, MacRae CA. C-Reactive protein in lone atrial fibrillation. Am. J. Cardiol. 2006;97:1346-1350.